October 3, 2019

Cannassure receives IMC-GAP Phase 1 for the Cultivation of Medical Cannabis

On October 3^rd, 2019, an inspection and certification agency, authorized by the Israel Medical Cannabis agency IMCA), granted Cannassure with an IMC-GAP Phase 1 standard approval for complying with quality and infrastructure standards throughout its newly built Indoor Grow Facility.

After having received the GSP standard approval for the company’s grow facility and a limited license for the practice and possession of a dangerous drug, Cannassure will be able to immediately begin cultivating its first cycle of 180 plants, a preliminary step to obtaining an
IMC-GAP certification and a practice license for the purpose of  growing medical cannabis plants on a commercial scale.